Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial

BACKGROUND: The most common clinical indication of aminoglycosides (AG) is the treatment of serious Gram-negative infections. The aim of this study was to evaluate plausible effects of atorvastatin on the biomarkers of acute kidney injury (AKI) in patients receiving amikacin. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Heydari, Behrooz, Khalili, Hossein, Beigmohammadi, Mohammad-Taghi, Abdollahi, Alireza, Karimzadeh, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393099/
https://www.ncbi.nlm.nih.gov/pubmed/28465698
http://dx.doi.org/10.4103/1735-1995.202150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393099/
https://www.ncbi.nlm.nih.gov/pubmed/28465698
http://dx.doi.org/10.4103/1735-1995.202150

Ejemplares similares